chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: slight sore throat; gigantic area at injection site; very hot at injection site; dizziness; swelled up at injection site; tired , body is uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (slight sore throat), VACCINATION SITE REACTION (gigantic area at injection site), VACCINATION SITE WARMTH (very hot at injection site), DIZZINESS (dizziness) and VACCINATION SITE SWELLING (swelled up at injection site) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ZOLPIDEM TARTRATE (AMBIEN) for an unknown indication.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (slight sore throat), VACCINATION SITE REACTION (gigantic area at injection site), VACCINATION SITE WARMTH (very hot at injection site), DIZZINESS (dizziness), VACCINATION SITE SWELLING (swelled up at injection site) and FATIGUE (tired , body is uncomfortable). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (slight sore throat), VACCINATION SITE REACTION (gigantic area at injection site), VACCINATION SITE WARMTH (very hot at injection site), DIZZINESS (dizziness), VACCINATION SITE SWELLING (swelled up at injection site) and FATIGUE (tired , body is uncomfortable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042BA1A and 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (tested positive for COVID). At the time of the report, COVID-19 (tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, SARS-CoV-2 test: positive (Positive) POSITIVE.         No concomitant medications provided. Treatment information was not provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Malaise, Nausea, Vomiting
Clinical narrative: Diarrhea; Vomiting; Not feeling well; Headache; Nauseas; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well), DIARRHOEA (Diarrhea), HEADACHE (Headache), NAUSEA (Nauseas) and VOMITING (Vomiting) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced MALAISE (Not feeling well), HEADACHE (Headache) and NAUSEA (Nauseas). On 17-Apr-2021, the patient experienced VOMITING (Vomiting). On 19-Apr-2021, the patient experienced DIARRHOEA (Diarrhea). On 19-Apr-2021, VOMITING (Vomiting) had resolved. At the time of the report, MALAISE (Not feeling well), DIARRHOEA (Diarrhea), HEADACHE (Headache) and NAUSEA (Nauseas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used included medication for arthritis and fibromyalgia.  Treatment medication included Imodium and Pepto Bismol.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arm; extreme tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (extreme tiredness) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 003B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (extreme tiredness). The patient was treated with AMIKACIN SULFATE (AMICARE) for Symptomatic treatment, at an unspecified dose and frequency. On 20-Apr-2021, PAIN IN EXTREMITY (sore arm) and FATIGUE (extreme tiredness) had resolved. Not Provided          No concomitant medications reported. Patient had applied ice pack on arm.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Feeling abnormal, Malaise, Pyrexia
Clinical narrative: like you're feeling when you're sick; temperature of 100; weaker; not feeling himself; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (like you're feeling when you're sick), PYREXIA (temperature of 100), ASTHENIA (weaker) and FEELING ABNORMAL (not feeling himself) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, the patient experienced MALAISE (like you're feeling when you're sick), PYREXIA (temperature of 100), ASTHENIA (weaker) and FEELING ABNORMAL (not feeling himself). At the time of the report, MALAISE (like you're feeling when you're sick), PYREXIA (temperature of 100), ASTHENIA (weaker) and FEELING ABNORMAL (not feeling himself) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment Tylenol
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: soreness in his arm; feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in his arm) and FATIGUE (feeling tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in his arm) and FATIGUE (feeling tired). At the time of the report, PAIN IN EXTREMITY (soreness in his arm) and FATIGUE (feeling tired) outcome was unknown.            Concomitant medication information not provided. Treatment information not provided. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-027170 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow-up information received on 16-JUN-2021, contains no significant information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-027170:1st dose case
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced COVID-19 (Covid). At the time of the report, COVID-19 (Covid) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No other relevant concomitant medication was reported.  No treatment information was reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Hot flush, Hyperhidrosis, Influenza like illness
Clinical narrative: Sweaty around the neck; Feels like hot flashes; Feels like being clammy; Itchy on left upper arm; Red on left upper arm; Fever 101F; Flu like symptoms; Chills; Achy; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), PAIN (Achy), PYREXIA (Fever 101F) and HYPERHIDROSIS (Sweaty around the neck) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039BZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Positive Covid-19 antibodies) in October 2020. Concomitant products included VALSARTAN for Blood pressure, VITAMIN D3 for Vitamin D supplementation, VITAMIN B COMPLEX, ZINC and ASCORBIC ACID, BIOFLAVONOIDS NOS (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS]) for Vitamin supplementation, UBIDECARENONE (CO-ENZYME Q10) for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills) and PAIN (Achy). On 20-Apr-2021, the patient experienced PYREXIA (Fever 101F). On 23-Apr-2021, the patient experienced HYPERHIDROSIS (Sweaty around the neck), HOT FLUSH (Feels like hot flashes), COLD SWEAT (Feels like being clammy), INJECTION SITE PRURITUS (Itchy on left upper arm) and INJECTION SITE ERYTHEMA (Red on left upper arm). On 20-Apr-2021, PYREXIA (Fever 101F) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), PAIN (Achy), HYPERHIDROSIS (Sweaty around the neck), HOT FLUSH (Feels like hot flashes), COLD SWEAT (Feels like being clammy), INJECTION SITE PRURITUS (Itchy on left upper arm) and INJECTION SITE ERYTHEMA (Red on left upper arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       On 19-April-2021 patient used Acetaminophen 2 tablets for fever.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: No specific follow-up information recorded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Pain, Pyrexia
Clinical narrative: Sweaty around the neck; Feels like hot flashes; Feels like being clammy; Itchy on left upper arm; Red on left upper arm; Fever 101F; Flu like symptoms; Chills; Achy; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), PAIN (Achy), PYREXIA (Fever 101F) and HYPERHIDROSIS (Sweaty around the neck) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039BZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Positive Covid-19 antibodies) in October 2020. Concomitant products included VALSARTAN for Blood pressure, VITAMIN D3 for Vitamin D supplementation, VITAMIN B COMPLEX, ZINC and ASCORBIC ACID, BIOFLAVONOIDS NOS (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS]) for Vitamin supplementation, UBIDECARENONE (CO-ENZYME Q10) for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills) and PAIN (Achy). On 20-Apr-2021, the patient experienced PYREXIA (Fever 101F). On 23-Apr-2021, the patient experienced HYPERHIDROSIS (Sweaty around the neck), HOT FLUSH (Feels like hot flashes), COLD SWEAT (Feels like being clammy), INJECTION SITE PRURITUS (Itchy on left upper arm) and INJECTION SITE ERYTHEMA (Red on left upper arm). On 20-Apr-2021, PYREXIA (Fever 101F) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), PAIN (Achy), HYPERHIDROSIS (Sweaty around the neck), HOT FLUSH (Feels like hot flashes), COLD SWEAT (Feels like being clammy), INJECTION SITE PRURITUS (Itchy on left upper arm) and INJECTION SITE ERYTHEMA (Red on left upper arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       On 19-April-2021 patient used Acetaminophen 2 tablets for fever.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: No specific follow-up information recorded.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product dose omission issue
Clinical narrative: Second dose of the vaccine will be scheduled after day 36 from the first dose; second dose was scheduled for 12APR2021 but she missed; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose of the vaccine will be scheduled after day 36 from the first dose) and PRODUCT DOSE OMISSION ISSUE (second dose was scheduled for 12APR2021 but she missed) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose of the vaccine will be scheduled after day 36 from the first dose) and PRODUCT DOSE OMISSION ISSUE (second dose was scheduled for 12APR2021 but she missed). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose of the vaccine will be scheduled after day 36 from the first dose) and PRODUCT DOSE OMISSION ISSUE (second dose was scheduled for 12APR2021 but she missed) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment was reported by the reporter
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Pyrexia, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: didnt recieve second dose; Running nose; Fever; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (didnt recieve second dose), RHINORRHOEA (Running nose), SARS-COV-2 TEST POSITIVE (COVID-19) and PYREXIA (Fever) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (didnt recieve second dose), RHINORRHOEA (Running nose) and PYREXIA (Fever). On 17-Feb-2021, SARS-COV-2 TEST POSITIVE (COVID-19) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (didnt recieve second dose) had resolved and RHINORRHOEA (Running nose) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, SARS-CoV-2 test: positive (Positive) diagnosed positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-May-2021: follow-up received on 22 may 2021.event outcome was added. On 21-Jul-2021: Non significant follow up-Supplemental Follow-up Questions for Report added
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Burning sensation, Constipation, Faeces discoloured
Clinical narrative: stomach cramps; stomach pain; stomach issues; constipation; burning sensation; sluggish; dark stool; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach cramps), ABDOMINAL PAIN UPPER (stomach pain), ABDOMINAL DISCOMFORT (stomach issues), CONSTIPATION (constipation) and BURNING SENSATION (burning sensation) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  Concomitant products included TRAZODONE for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach cramps), ABDOMINAL PAIN UPPER (stomach pain), ABDOMINAL DISCOMFORT (stomach issues), CONSTIPATION (constipation), BURNING SENSATION (burning sensation), SLUGGISHNESS (sluggish) and FAECES DISCOLOURED (dark stool). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (stomach cramps), ABDOMINAL PAIN UPPER (stomach pain), ABDOMINAL DISCOMFORT (stomach issues), CONSTIPATION (constipation), BURNING SENSATION (burning sensation), SLUGGISHNESS (sluggish) and FAECES DISCOLOURED (dark stool) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took  laxatives, stool softener, and fiber to relieve his symptoms.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Sluggishness
Clinical narrative: stomach cramps; stomach pain; stomach issues; constipation; burning sensation; sluggish; dark stool; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach cramps), ABDOMINAL PAIN UPPER (stomach pain), ABDOMINAL DISCOMFORT (stomach issues), CONSTIPATION (constipation) and BURNING SENSATION (burning sensation) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  Concomitant products included TRAZODONE for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach cramps), ABDOMINAL PAIN UPPER (stomach pain), ABDOMINAL DISCOMFORT (stomach issues), CONSTIPATION (constipation), BURNING SENSATION (burning sensation), SLUGGISHNESS (sluggish) and FAECES DISCOLOURED (dark stool). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (stomach cramps), ABDOMINAL PAIN UPPER (stomach pain), ABDOMINAL DISCOMFORT (stomach issues), CONSTIPATION (constipation), BURNING SENSATION (burning sensation), SLUGGISHNESS (sluggish) and FAECES DISCOLOURED (dark stool) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took  laxatives, stool softener, and fiber to relieve his symptoms.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Fever; Very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very sore arm) and PYREXIA (Fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (Very sore arm). On 19-Apr-2021, the patient experienced PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Very sore arm) and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. Treatment included Tylenol.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Small rash appear, under her arm near her arm pit; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Small rash appear, under her arm near her arm pit) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced RASH (Small rash appear, under her arm near her arm pit). At the time of the report, RASH (Small rash appear, under her arm near her arm pit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Metallic tatste in mouth lasting 4-6 hours the day patient received 1st dose on 19Apr2021; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic tatste in mouth lasting 4-6 hours the day patient received 1st dose on 19Apr2021) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced DYSGEUSIA (Metallic tatste in mouth lasting 4-6 hours the day patient received 1st dose on 19Apr2021). On 19-Apr-2021, DYSGEUSIA (Metallic tatste in mouth lasting 4-6 hours the day patient received 1st dose on 19Apr2021) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment medication not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow up document received contains No New Information.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Nausea, Pain in extremity
Clinical narrative: diarrhea; diarrhea; little nauseous; aching in her joints; no to little soreness in her left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (no to little soreness in her left arm), the second episode of DIARRHOEA (diarrhea), the first episode of DIARRHOEA (diarrhea), NAUSEA (little nauseous) and ARTHRALGIA (aching in her joints) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included Heart disorder.    On 12-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (no to little soreness in her left arm). On 15-Apr-2021, the patient experienced the first episode of DIARRHOEA (diarrhea), NAUSEA (little nauseous) and ARTHRALGIA (aching in her joints). On 20-Apr-2021, the patient experienced the second episode of DIARRHOEA (diarrhea). At the time of the report, PAIN IN EXTREMITY (no to little soreness in her left arm) had resolved, last episode of DIARRHOEA (diarrhea) outcome was unknown and NAUSEA (little nauseous) and ARTHRALGIA (aching in her joints) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood pressure medicine. Treatment medication not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Malaise
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of malaise (hasn't been feeling well) and arthralgia (recently hurt her shoulder moving/ache in her shoulder) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced malaise (hasn't been feeling well) and arthralgia (recently hurt her shoulder moving/ache in her shoulder). At the time of the report, malaise (hasn't been feeling well) and arthralgia (recently hurt her shoulder moving/ache in her shoulder) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant medication and treatment information not provided. Most recent follow-up information incorporated: On May 21, 2021: Updated event outcome (resolved); updated 2nd dose information.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: A very pronounced metallic taste in his mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (A very pronounced metallic taste in his mouth) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSGEUSIA (A very pronounced metallic taste in his mouth). At the time of the report, DYSGEUSIA (A very pronounced metallic taste in his mouth) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No treatment information provided.   This case was linked to MOD-2021-209109 (Patient Link).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Vaccination site pain, Vaccination site swelling
Clinical narrative: Pain was radiating to her chest & chest pain; Trouble breathing/a little diffeculty breathing; Arm was swollen; Arm was really sore; This spontaneous case was reported by a physician and describes the occurrence of CHEST PAIN (Pain was radiating to her chest & chest pain), DYSPNOEA (Trouble breathing/a little diffeculty breathing), VACCINATION SITE SWELLING (Arm was swollen) and VACCINATION SITE PAIN (Arm was really sore) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Pain was radiating to her chest & chest pain), DYSPNOEA (Trouble breathing/a little diffeculty breathing), VACCINATION SITE SWELLING (Arm was swollen) and VACCINATION SITE PAIN (Arm was really sore). At the time of the report, CHEST PAIN (Pain was radiating to her chest & chest pain), DYSPNOEA (Trouble breathing/a little diffeculty breathing), VACCINATION SITE SWELLING (Arm was swollen) and VACCINATION SITE PAIN (Arm was really sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medicine include Baby aspirin one day   Treatment information was not provided
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Cold sweat, Diarrhoea, Discomfort, Dyspnoea
Clinical narrative: he woke up with cold sweat; He had diarrhea for few hours early in the morning; Since then he feels run down; He feels shortness of breath; His lungs feels as if someone is sitting on them (tight and heavy).; His stomach feels squeezy; he threw up; He feels tired; Patient felt nauseated 2 days after receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (he woke up with cold sweat), DIARRHOEA (He had diarrhea for few hours early in the morning), FEELING ABNORMAL (Since then he feels run down), DYSPNOEA (He feels shortness of breath) and DISCOMFORT (His lungs feels as if someone is sitting on them (tight and heavy).) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included NAPROXEN SODIUM (ALEVE) for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 26-Mar-2021, the patient experienced NAUSEA (Patient felt nauseated 2 days after receiving 1st dose). On 14-Apr-2021, the patient experienced COLD SWEAT (he woke up with cold sweat), DIARRHOEA (He had diarrhea for few hours early in the morning), FEELING ABNORMAL (Since then he feels run down), DYSPNOEA (He feels shortness of breath), DISCOMFORT (His lungs feels as if someone is sitting on them (tight and heavy).), ABDOMINAL DISCOMFORT (His stomach feels squeezy), VOMITING (he threw up) and FATIGUE (He feels tired). At the time of the report, COLD SWEAT (he woke up with cold sweat), DIARRHOEA (He had diarrhea for few hours early in the morning), FEELING ABNORMAL (Since then he feels run down), DYSPNOEA (He feels shortness of breath), DISCOMFORT (His lungs feels as if someone is sitting on them (tight and heavy).), ABDOMINAL DISCOMFORT (His stomach feels squeezy), NAUSEA (Patient felt nauseated 2 days after receiving 1st dose), VOMITING (he threw up) and FATIGUE (He feels tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported.  Patient scheduled to get 2nd dose on 21-APR-2021.  Patient stated that the reported events are not due to Moderna COVID-19 Vaccine  but due to his stomach infection.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Patient reported about events and stated that reported events was not due to moderna vaccine and event outcome was updated from unknown to recovered.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Nausea, Vomiting
Clinical narrative: he woke up with cold sweat; He had diarrhea for few hours early in the morning; Since then he feels run down; He feels shortness of breath; His lungs feels as if someone is sitting on them (tight and heavy).; His stomach feels squeezy; he threw up; He feels tired; Patient felt nauseated 2 days after receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (he woke up with cold sweat), DIARRHOEA (He had diarrhea for few hours early in the morning), FEELING ABNORMAL (Since then he feels run down), DYSPNOEA (He feels shortness of breath) and DISCOMFORT (His lungs feels as if someone is sitting on them (tight and heavy).) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included NAPROXEN SODIUM (ALEVE) for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 26-Mar-2021, the patient experienced NAUSEA (Patient felt nauseated 2 days after receiving 1st dose). On 14-Apr-2021, the patient experienced COLD SWEAT (he woke up with cold sweat), DIARRHOEA (He had diarrhea for few hours early in the morning), FEELING ABNORMAL (Since then he feels run down), DYSPNOEA (He feels shortness of breath), DISCOMFORT (His lungs feels as if someone is sitting on them (tight and heavy).), ABDOMINAL DISCOMFORT (His stomach feels squeezy), VOMITING (he threw up) and FATIGUE (He feels tired). At the time of the report, COLD SWEAT (he woke up with cold sweat), DIARRHOEA (He had diarrhea for few hours early in the morning), FEELING ABNORMAL (Since then he feels run down), DYSPNOEA (He feels shortness of breath), DISCOMFORT (His lungs feels as if someone is sitting on them (tight and heavy).), ABDOMINAL DISCOMFORT (His stomach feels squeezy), NAUSEA (Patient felt nauseated 2 days after receiving 1st dose), VOMITING (he threw up) and FATIGUE (He feels tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported.  Patient scheduled to get 2nd dose on 21-APR-2021.  Patient stated that the reported events are not due to Moderna COVID-19 Vaccine  but due to his stomach infection.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Patient reported about events and stated that reported events was not due to moderna vaccine and event outcome was updated from unknown to recovered.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: hair has been falling out one week after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (hair has been falling out one week after the second dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Patient on multiple concomitant medications did not report medical history). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), VITAMIN D NOS, LOSARTAN, METOPROLOL, CETIRIZINE, OMEPRAZOLE and PROBIOTICS NOS.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ALOPECIA (hair has been falling out one week after the second dose). At the time of the report, ALOPECIA (hair has been falling out one week after the second dose) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Injection site discolouration, Lymphadenopathy, Pyrexia, Vaccination site rash
Clinical narrative: injection site turned black and blue; high raised rash a few days later; fever; glands under her left arm are "quite miserable"; swollen glands under both arms; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOLOURATION (injection site turned black and blue), VACCINATION SITE RASH (high raised rash a few days later), PYREXIA (fever), LYMPHADENOPATHY (glands under her left arm are "quite miserable") and LYMPHADENOPATHY (swollen glands under both arms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE DISCOLOURATION (injection site turned black and blue), VACCINATION SITE RASH (high raised rash a few days later), PYREXIA (fever), LYMPHADENOPATHY (glands under her left arm are "quite miserable") and LYMPHADENOPATHY (swollen glands under both arms). At the time of the report, INJECTION SITE DISCOLOURATION (injection site turned black and blue), VACCINATION SITE RASH (high raised rash a few days later), PYREXIA (fever), LYMPHADENOPATHY (glands under her left arm are "quite miserable") and LYMPHADENOPATHY (swollen glands under both arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medicines were not included   This case was linked to MOD-2021-081357 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Musculoskeletal stiffness
Clinical narrative: Stiffness leading to pain from neck movement; throbbing head pain; soreness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness leading to pain from neck movement), INJECTION SITE PAIN (soreness around the injection site) and HEADACHE (throbbing head pain) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced INJECTION SITE PAIN (soreness around the injection site). On 01-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness leading to pain from neck movement) and HEADACHE (throbbing head pain). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness leading to pain from neck movement), INJECTION SITE PAIN (soreness around the injection site) and HEADACHE (throbbing head pain) outcome was unknown.            No Relevant concomitant medications was reported.  Treatment information included Ibuprofen daily.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: positive covid patients after first dose administration; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of COVID-19 (positive covid patients after first dose administration) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (positive covid patients after first dose administration). At the time of the report, COVID-19 (positive covid patients after first dose administration) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Swelling face
Clinical narrative: puffy face; swollen lip; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LIP SWELLING (swollen lip) and SWELLING FACE (puffy face) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced LIP SWELLING (swollen lip). On 20-Apr-2021, the patient experienced SWELLING FACE (puffy face). At the time of the report, LIP SWELLING (swollen lip) had resolved and SWELLING FACE (puffy face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information not provided. Treatment information included cetirizine for swollen lip and diphenhydramine for puffy face.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Incorrect dose administered by product
Clinical narrative: I took a third dose.; Partial dose; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT DOSE ADMINISTERED BY PRODUCT (Partial dose) and EXTRA DOSE ADMINISTERED (I took a third dose.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B or D /210A, 026A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced INCORRECT DOSE ADMINISTERED BY PRODUCT (Partial dose). On 01-Apr-2021, the patient experienced EXTRA DOSE ADMINISTERED (I took a third dose.). On 18-Mar-2021, INCORRECT DOSE ADMINISTERED BY PRODUCT (Partial dose) had resolved. On 01-Apr-2021, EXTRA DOSE ADMINISTERED (I took a third dose.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication information was reported. The patient was not sure about  3rd dose lot number. She stated that she has willingly taken the third dose as only partial dose was administered during her second dose.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itchiness; pain; Little swollen; red; lump; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain), VACCINATION SITE MASS (lump), VACCINATION SITE SWELLING (Little swollen), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PRURITUS (Itchiness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain), VACCINATION SITE MASS (lump), VACCINATION SITE SWELLING (Little swollen) and VACCINATION SITE ERYTHEMA (red). On 19-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness). At the time of the report, VACCINATION SITE PAIN (pain), VACCINATION SITE MASS (lump), VACCINATION SITE SWELLING (Little swollen), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PRURITUS (Itchiness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Eye irritation, Skin burning sensation
Clinical narrative: Skin burned after laying in the sun; Eyes burned after laying in the sun; This spontaneous case was reported by a consumer and describes the occurrence of SKIN BURNING SENSATION (Skin burned after laying in the sun) and EYE IRRITATION (Eyes burned after laying in the sun) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced SKIN BURNING SENSATION (Skin burned after laying in the sun) and EYE IRRITATION (Eyes burned after laying in the sun). At the time of the report, SKIN BURNING SENSATION (Skin burned after laying in the sun) and EYE IRRITATION (Eyes burned after laying in the sun) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medication details were reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow-up information was received on 17-JUN-2021 contains no new information.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tests positive for COVID after receiving the first moderna vaccine dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (tests positive for COVID after receiving the first moderna vaccine dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (tests positive for COVID after receiving the first moderna vaccine dose). At the time of the report, COVID-19 (tests positive for COVID after receiving the first moderna vaccine dose) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive (Positive) The patient was tested positive for covid after receiving first dose..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. Treatment medication was not provided.   This case was linked to MOD-2021-081346 (E2B Linked Report).; Sender's Comments:  MOD-2021-081346:patient 1